CRE Notice to FDA: TPSAC Violates FACA

CRE continues to identify FDA/TPSAC  non-compliance with FACA.  Would senior career civil servants who are charged with ensuring FACA compliance permit such actions  for any products other than tobacco?

See the attached memorandum which explains in detail the reasons why the Constitutents Subcommitee is in violation of FACA. Hopefully, FDA will address these issues  administratively so as not to necessiate other corrective actions.

CRE’s objective is to make FDA aware of  its non-compliance with FACA so it will not make the same mistakes when it establshes the menthol subcommittee.

See CRE  coverage in  FDA Week

Leave a Reply